Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Coronavirus Infection in 2019 (COVID-19)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT05594147
What this trial is testing

An Observational Study, Called ROCURS, to Learn About COVID-19 Related Outcomes in People With Cancer Who Are Treated With Tyrosine Kinase Inhibitors (TKIs) Including Regorafenib or Sorafenib

Who this might be right for
Malignant Solid TumorsCoronavirus Disease 2019 (COVID-19)SARS-CoV-2 Infection
Bayer 4,103
Testing effectiveness (Phase 2)Study completedNCT04346199
What this trial is testing

Acalabrutinib Study With Best Supportive Care Versus Best Supportive Care in Subjects Hospitalized With COVID-19.

Who this might be right for
COVID-19
AstraZeneca 177
Not applicableStudy completedNCT06638957
What this trial is testing

Impact of the COVID-19 Pandemic on Oncologic Outcomes in Colorectal Cancer

Who this might be right for
Colorectal CarcinomaCOVID 19
In Ja Park 14,951
Large-scale testing (Phase 3)UnknownNCT04434248
What this trial is testing

An Adaptive Study of Favipiravir Compared to Standard of Care in Hospitalized Patients With COVID-19

Who this might be right for
COVID-19
Chromis LLC 330
Early research (Phase 1)Study completedNCT04483375
What this trial is testing

Safety, Tolerability and Pharmacokinetics of SCTA01, an Anti-SARS-CoV-2 Monoclonal Antibody, in Healthy Chinese Subjects

Who this might be right for
Coronavirus Disease 2019(COVID-19)
Sinocelltech Ltd. 33
Not applicableUnknownNCT05799534
What this trial is testing

Post-Coronavirus Disease of 2019 (COVID-19) Rehabilitation Clinics in Saudi Arabia

Who this might be right for
FatigueCardiopulmonary ArrestPhysical Inactivity+3 more
Majmaah University 400
Not applicableStudy completedNCT05228639
What this trial is testing

COVID-19 Surveillance in Rural Mozambique for Prompt and Effective Response

Who this might be right for
COVID-19
Centro de Investigacao em Saude de Manhica 6,494
Large-scale testing (Phase 3)UnknownNCT05128643
What this trial is testing

Clinical Study on the Immune Program of Recombinant Novel Coronavirus（COVID-19) Vaccine (CHO Cell)

Who this might be right for
Coronavirus Disease 2019
Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. 300
Testing effectiveness (Phase 2)Ended earlyNCT04834908
What this trial is testing

Evaluation of Equine Antibody Treatment in Patients With COVID 19 Infection

Who this might be right for
SARS-CoV-2 Infection
Bharat Serums and Vaccines Limited 7
Large-scale testing (Phase 3)Study completedNCT04374526
What this trial is testing

Early transfusIon of Convalescent Plasma in Elderly COVID-19 Patients. to Prevent Disease Progression.

Who this might be right for
Coronavirus Disease 2019 )COVID-19)
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 29
Not applicableStudy completedNCT04371315
What this trial is testing

Risk Factors, Clinical Characteristics and Outcomes of Acute Infection With Coronavirus 2019 (COVID-19) In Children

Who this might be right for
Corona Virus InfectionPediatric CancerAdult Children+1 more
St. Jude Children's Research Hospital 33
Not applicableStudy completedNCT05513248
What this trial is testing

Perioperative Outcomes of Anatomic Lung Resections in Patients Who Recovered From Coronavirus Disease 2019

Who this might be right for
COVID-19Lung CancerLung TB+1 more
Lung Center of the Philippines 16
Not applicableStudy completedNCT04375761
What this trial is testing

COVID-19: Human Epidemiology and Response to SARS-CoV-2

Who this might be right for
Coronavirus Disease 2019 (COVID-19)SARS-CoV-2
National Institute of Allergy and Infectious Diseases (NIAID) 5,599
Testing effectiveness (Phase 2)UnknownNCT04854928
What this trial is testing

Study to Evaluate a Single Dose of LTX-109 in Subjects With COVID-19 (Coronavirus Disease 2019) Infection.

Who this might be right for
COVID-19
Pharma Holdings AS 60
Testing effectiveness (Phase 2)UnknownNCT04396067
What this trial is testing

Aerosol Combination Therapy of All-trans Retinoic Acid and Isotretinoin as A Novel Treatment for Inducing Neutralizing Antibodies in COVID -19 Infected Patients Better Than Vaccine : An Innovative Treatment

Who this might be right for
COVID-19
Kafrelsheikh University 360
Testing effectiveness (Phase 2)Ended earlyNCT04884295
What this trial is testing

Dose-Finding, Safety, and Efficacy Study of XVR011 Added to Standard of Care in Patients Hospitalised for COVID-19

Who this might be right for
Covid19
ExeVir Bio BV 27
Not applicableUnknownNCT05366244
What this trial is testing

An Observational Study in Patients With Mild to Moderate COVID-19

Who this might be right for
COVID-19
Shanghai Pudong Hospital 100
Not applicableUnknownNCT04452942
What this trial is testing

Cytokine and Eicosanoid Mediators in Coronavirus Disease 2019 (COVID-19)

Who this might be right for
COVID-19
EicOsis Human Health Inc. 30
Not applicableStudy completedNCT04760990
What this trial is testing

Assess the Potential Impact of Disease Modifying Therapies on COVID-19 Outcomes and the Antibody Response Following an Infection With SARS-CoV-2 in Patients With Multiple Sclerosis Within the Swiss Multiple Sclerosis Cohort.

Who this might be right for
Multiple SclerosisCOVID-19 (Severe Coronavirus Disease 2019)
University Hospital, Basel, Switzerland 1,181
Testing effectiveness (Phase 2)UnknownNCT05047783
What this trial is testing

Masitinib in Patients With Symptomatic Mild to Moderate COVID-19

Who this might be right for
Covid19SARS-CoV2 InfectionCoronavirus Disease 2019
AB Science 78
Next Page